Publications (141) Antonio Pineda Lucena publications

2024

  1. AI is a viable alternative to high throughput screening: a 318-target study

    Scientific Reports, Vol. 14, Núm. 1

  2. GeNNius: an ultrafast drug-target interaction inference method based on graph neural networks

    Bioinformatics (Oxford, England), Vol. 40, Núm. 1

  3. HDACi vorinostat protects muscle from degeneration after acute rotator cuff injury in mice

    Bone and Joint Research, Vol. 12, Núm. 4, pp. 169-183

  4. Modulation of tumor microenvironment by targeting histone acetylation in bladder cancer

    Cell Death Discovery, Vol. 10, Núm. 1

  5. Pharmacological inhibition of the integrated stress response accelerates disease progression in an amyotrophic lateral sclerosis mouse model

    British Journal of Pharmacology, Vol. 181, Núm. 3, pp. 495-508

2023

  1. AG5 is a potent non-steroidal anti-inflammatory and immune regulator that preserves innate immunity

    Biomedicine and Pharmacotherapy, Vol. 169

  2. Identification and experimental validation of druggable epigenetic targets in hepatoblastoma

    Journal of Hepatology, Vol. 79, Núm. 4, pp. 989-1005

  3. IgG antibody response to pneumococcal-conjugated vaccine (Prevenar®13) in children with immunodeficiency disorders

    Medical Microbiology and Immunology, Vol. 212, Núm. 1, pp. 93-102

  4. NMR-Based Mitochondria Metabolomic Profiling: A New Approach To Reveal Cancer-Associated Alterations

    Analytical Chemistry, Vol. 95, Núm. 45, pp. 16539-16548

  5. Omics-Based Approaches for the Characterization of Pompe Disease Metabolic Phenotypes

    Biology, Vol. 12, Núm. 9

  6. Photodynamic nasal SARS-CoV-2 decolonization shortens infectivity and influences specific T-Cell responses

    Frontiers in Cellular and Infection Microbiology, Vol. 13

  7. Signature-driven repurposing of Midostaurin for combination with MEK1/2 and KRASG12C inhibitors in lung cancer

    Nature Communications, Vol. 14, Núm. 1

2022

  1. CM-352 Efficacy in a Mouse Model of Anticoagulant-Associated Intracranial Hemorrhage

    Thrombosis and Haemostasis, Vol. 122, Núm. 8, pp. 1314-1325

  2. Discovery of serum biomarkers for diagnosis of tuberculosis by NMR metabolomics including cross-validation with a second cohort

    Biomedical Journal, Vol. 45, Núm. 4, pp. 654-664

  3. G9a inhibition by CM-272: Developing a novel anti-tumoral strategy for castration-resistant prostate cancer using 2D and 3D in vitro models

    Biomedicine and Pharmacotherapy, Vol. 150

  4. Impact of CYLD on chromatin structure and histone methylation in malignant melanoma

    International Journal of Molecular Medicine, Vol. 49, Núm. 5

  5. Lactobacillus supports Clostridiales to restrict gut colonization by multidrug-resistant Enterobacteriaceae

    Nature Communications, Vol. 13, Núm. 1

  6. Metabolic Alterations in a Drosophila Model of Parkinson’s Disease Based on DJ-1 Deficiency

    Cells, Vol. 11, Núm. 3

  7. Metabolic Phenotyping in Prostate Cancer Using Multi-Omics Approaches

    Cancers, Vol. 14, Núm. 3

  8. Microbiome-mediated fructose depletion restricts murine gut colonization by vancomycin-resistant Enterococcus

    Nature Communications, Vol. 13, Núm. 1